VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$5.08
-0.28 (-5.22%)
Open$5.31
Previous Close$5.36
Day High$5.50
Day Low$4.70
52W High$9.82
52W Low$3.28
Volume—
Avg Volume36.9K
Market Cap91.55M
P/E Ratio—
EPS$-1.03
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+88.8% upside
Current
$5.08
$5.08
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 60.19M | 38.11M | 35.73M |
| Net Income | -30,260,885 | -17,243,761 | 6.74M |
| Profit Margin | -50.3% | -47.8% | 18.9% |
| EBITDA | -22,388,838 | -13,466,757 | 12.85M |
| Free Cash Flow | — | — | 8.80M |
| Rev Growth | +57.9% | +57.9% | +7.9% |
| Debt/Equity | 0.04 | 0.04 | 0.56 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |